|
|
Volumn 310, Issue 5751, 2005, Pages 1132-1134
|
|
Nanotechnology takes aim at cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
ALPHA 1 ANTICHYMOTRYPSIN;
ANTINEOPLASTIC AGENT;
CADMIUM;
CAMPTOTHECIN DERIVATIVE;
CARCINOEMBRYONIC ANTIGEN;
CONTRAST MEDIUM;
CYCLODEXTRIN;
CYCLOSERTCAMPTOTHECIN;
DRUG METABOLITE;
GOLD;
INDIUM;
INGN 401;
IRINOTECAN;
IRON OXIDE;
MONOCLONAL ANTIBODY;
MRX 952;
MUCIN 1;
NANOPARTICLE;
PACLITAXEL;
PHOTOFRIN;
POLYMER;
PROSTATE SPECIFIC ANTIGEN;
SELENIUM;
TELLURIUM;
TELOMERASE;
TUMOR MARKER;
ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VERIGENE;
VIVAGEL;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RESEARCH;
DEVICE;
DIAGNOSTIC IMAGING;
DRUG APPROVAL;
DRUG DELIVERY SYSTEM;
DRUG INDICATION;
ELECTRODE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENE AMPLIFICATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIGHT EMITTING DIODE;
LUNG CANCER;
LYMPH NODE BIOPSY;
MEDICAL TECHNOLOGY;
NANOTECHNOLOGY;
NONHUMAN;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ONCOLOGY;
PRIORITY JOURNAL;
SEMICONDUCTOR;
SENTINEL LYMPH NODE;
SOLID TUMOR;
ARTICLE;
MORTALITY;
NEOPLASM;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMANS;
MEDICAL ONCOLOGY;
NANOTECHNOLOGY;
NEOPLASMS;
|
|
EID: 27944494320
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.310.5751.1132 Document Type: Note |
|
Times cited : (166)
|
|
References (0)
|